Reporting from the frontiers of health & medicine. Sign up for any of our newsletters here: https://nitter.cf/t.co/CBx3GZBv31
Joined July 2015
- Tweets89.6K
- Following4.7K
- Followers165K
- Likes45K
STAT retweeted
Helen Branswell was the most prescient reporter on Covid, and a wonderful colleague and friend. This video she recorded in late summer is an inspiration to us all.
Last night, STAT's Executive Editor Rick Berke accepted, in memory of Helen Branswell, the Kovler Prize for Trust in Life Science Journalism.
Watch this video that Helen recorded in late summer to accept the award.
We miss you, Helen.
youtube.com/watch?v=Rsu5Zr8I…
STAT retweeted
This week's Biotech Scorecard newsletter:
-- Vertex $VRTX kidney disease drug scrutinized for infection risk $VERA $OTSKY
-- 10 FDA drug approval decisions on tap before 2026 ends.
statnews.com/2026/10/29/biot…
STAT retweeted
Two reporters did what has eluded so many others: penetrating the behemoth that is Epic
“It’s very clear Epic owns the market. Its prices are extraordinary. It has killed innovators left and right — it’s time for a change.” A must-read story from Casey Ross and @brittanytrang, who are investigating the electronic health records giant Epic. statnews.com/2026/10/28/epic…
STAT retweeted
RFK Jr. is making his closing argument to Americans ahead of the midterms election: Vote Republican and we'll Make America Healthy Again, stick with changing vaccine policy, and crack down on fraud (which, in turn, will lower costs, he says). My latest: statnews.com/2026/10/29/rfk-…
STAT retweeted
El-Sayed on RFK Jr.'s to @AnilOza16:
"[I]t’s ironic to hear a guy who’s trafficked in eugenicist terms, who rejects science outright ... lecture voters about an Arab American scientist with two doctoral degrees who believes in science, like vaccines.”
statnews.com/2026/10/28/abdu…
STAT retweeted
New investigation from @statnews:
Epic's control over access to hospitals' health data means that it is picking and choosing winners in health tech and AI, and can throttle access to those it deems unworthy, or competitive with its own products. statnews.com/2026/10/28/epic…
STAT retweeted
There is no better reporter anywhere covering rare diseases than STAT's @Jasonmmast. Today, another masterpiece:
Pennsylvania Dutch country, tired of waiting for biopharma, builds drug company of its own statnews.com/2026/10/27/gene…
STAT retweeted
I spoke with Moderna $MRNA CEO Stéphane Bancel about intismeran and what's next for the cancer vaccine and the biotech he runs.
"We know the clinical impact in the Phase 3 study is real and big, so we need to go and be aggressive. We need to explore the biology. There will be some risk, because it’s not going to work everywhere."
Read the Q&A:
statnews.com/2026/10/26/mode… #ESMO26
STAT retweeted
After a cancer vaccine’s first success, the race is on to expand the impact statnews.com/2026/10/25/mrna…
STAT retweeted
This week's Readout LOUD podcast is one we wish we didn't have to produce: A tribute to STAT's North Star: Helen Branswell.
Please give it a listen, available on all the podcast platforms.
statnews.com/2026/10/23/read…
STAT retweeted
Only good and correct takes within statnews.com/2026/10/23/expl…
STAT retweeted
#ESMO26 embargo lifted following breach.
Detailed data confirm Moderna $MRNA and Merck $MRK cancer vaccine met key endpoints in melanoma trial
Personalized mRNA therapy reduced disease recurrence by 42% compared to standard treatment
statnews.com/2026/10/22/esmo…
STAT retweeted
Housekeeping note: I'm flying to Madrid tonight to cover #ESMO26, joined by my colleague @DrewQJoseph
We'll have stories + our ESMO pop-up newsletter. If you want to receive the latter (it's free) you can sign up here:
statnews.com/signup/esmo-30-…
STAT retweeted
Mark Cuban wants to crack open the market for rare disease treatments statnews.com/2026/10/21/mark… via @statnews
STAT retweeted
So all the discussion here on X has led me to think -- quite a bit! -- about the new film.
And here is where I landed. The film is, indeed, brilliant. I loved the movie. But I hated myself — and everyone else — for loving it, because I felt like that love demonstrated exactly why Holmes can seem to have such an eerie power over people.
So here's why I wish you didn’t want to see Nathan Fielder’s Elizabeth Holmes documentary
TLDR: Movie is great, humans suck.
statnews.com/2026/10/20/eliz…
STAT retweeted
Health care ballot measures to watch: statnews.com/2026/10/20/what…
STAT retweeted
So @TylerShultz_ as a Theranos whistleblower. And he wrote the piece you need to read about ‘You Can See Everything.’
Elizabeth Holmes is still lying, he says. And the filmmakers, while creating a great piece of art, fall short on looking outside the walls of her apartment to document that.
One key detail: "My wife had to squeeze my arm to prevent me from jumping out of my seat in the theater and screaming, THAT IS NOT THE DEVICE."
Again, that device Holmes showed? It's not the one we're talking about!!!!
Having seen the film, I basically agree with Tyler's take.
statnews.com/2026/10/19/eliz…
STAT retweeted
I've done a bit of personal writing over the years. Today I published by far the most difficult essay I've written. On @STATNews, I share the story of my mother, Regina Bosch. She was brilliant--three Ivy degrees--and funny and charismatic. She was also seriously mentally ill.
ALT A woman laughs while leaning against a man's shoulder
STAT retweeted
@ScottGottliebMD, Michelle Groman, @AmiBhattMD, Monica Bertagnolli, Fritz Bittenbender, Cory Anderson, and more I've probably missed. Forgive me!
If you're here at the #STATSummit and you've written for First Opinion or want to, please come find me!
STAT retweeted
If you care about biotech and drug development watch this interview with Matt Gline, the CEO of Roivant, a biotech firm that is now worth $24 billion.
He talks about why he thinks predictions about AI from people like Anthropic’s Dario Amodei are overly optimistic.
“If Dario is right and I'm wrong, and he cures every disease in five years, man, are we all the winners from that outcome,” Gline said.
“I think if you work in this industry, it is very hard not to be skeptical of any of those claims. Because, and I've said this in other settings recently too, biotech is a wood chipper that like is built to like ingest souls and shred them. It's just like such a hard business that like someone comes and they're like, oh, but I've built a computer and I'm going to push a button and all of that goes away and it just works. Like that is probably not the way that's going to go.”